Calidi Biotherapeutics, Inc. (CLDI)
Stock-Based Compensation
$1.37M
TTM · Period ending: · USD
CLDI Stock-Based Compensation
Latest reported$1.37Mperiod ending
Latest reported$1.37Mperiod ending
CLDI TTM Stock-Based Comp ($2.81M → $1.37M)
TTM stock-based compensation
High-resolution chart · PNG
CLDI stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 1,367,000 | |
| 1,732,000 | |
| 2,108,000 | |
| 2,284,000 | |
| 2,447,000 | |
| 2,676,000 | |
| 2,957,000 | |
| 3,517,000 | |
| 3,934,000 | |
| 4,263,000 | |
| 4,809,000 | |
| 4,681,000 | |
| 3,572,000 | |
| 3,428,000 | |
| 3,460,000 | |
| 2,814,000 | |
| 2,814,000 |